This federal contract award, valued at $14,596.46, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,058 units of Tamsulosin Hydrochloride 0.4 mg capsules, a common prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a large pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products.
Generated 10/1/24, 9:42 AM